IDH mutation is more commonly seen in lower grade gliomas (81%), including astrocytoma (69%), oligoastrocytoma (87%) and oligodendroglioma (89%); whereas the frequency of IDH mutation is substantially lower in primary glioblastoma (~8%)1,9. This evidence concerns the gene IDH1 and central nervous system cancer.